BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 29692381)

  • 1. Current Status of Community-Acquired Pneumonia in Patients with Chronic Obstructive Pulmonary Disease.
    Liu DS; Han XD; Liu XD
    Chin Med J (Engl); 2018 May; 131(9):1086-1091. PubMed ID: 29692381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.
    Williams NP; Coombs NA; Johnson MJ; Josephs LK; Rigge LA; Staples KJ; Thomas M; Wilkinson TM
    Int J Chron Obstruct Pulmon Dis; 2017; 12():313-322. PubMed ID: 28176888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased risk of community-acquired pneumonia in COPD patients with comorbid cardiovascular disease.
    Lin SH; Perng DW; Chen CP; Chai WH; Yeh CS; Kor CT; Cheng SL; Chen JJ; Lin CH
    Int J Chron Obstruct Pulmon Dis; 2016; 11():3051-3058. PubMed ID: 27980402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The mortality risk factor of community acquired pneumonia patients with chronic obstructive pulmonary disease: a retrospective cohort study.
    Dai RX; Kong QH; Mao B; Xu W; Tao RJ; Wang XR; Kong QY; Xu JF
    BMC Pulm Med; 2018 Jan; 18(1):12. PubMed ID: 29357862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD is associated with increased mortality in patients with community-acquired pneumonia.
    Restrepo MI; Mortensen EM; Pugh JA; Anzueto A
    Eur Respir J; 2006 Aug; 28(2):346-51. PubMed ID: 16611653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific pathogens as predictors of poor long-term prognosis after hospital discharge for community-acquired pneumonia.
    Akiyama Y; Ishiguro T; Uozumi R; Nishida T; Kobayashi Y; Takayanagi N
    Respir Med; 2021 Jan; 176():106279. PubMed ID: 33302145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacterial Patterns and Empiric Antibiotic Use in COPD Patients With Community-Acquired Pneumonia.
    Pascual-Guardia S; Amati F; Marin-Corral J; Aliberti S; Gea J; Soni NJ; Rodriguez A; Sibila O; Sanz F; Sotgiu G; Marcos PJ; Uranga A; Milenkovic B; Meyer CN; Kolditz M; Anzueto AR; Restrepo MI;
    Arch Bronconeumol; 2023 Feb; 59(2):90-100. PubMed ID: 36376121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hospitalization due to community-acquired pneumonia in patients with chronic obstructive pulmonary disease: incidence, epidemiology and outcomes.
    Bordon J; Slomka M; Gupta R; Furmanek S; Cavallazzi R; Sethi S; Niederman M; Ramirez JA;
    Clin Microbiol Infect; 2020 Feb; 26(2):220-226. PubMed ID: 31254714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbid pulmonary disease and risk of community-acquired pneumonia in COPD patients.
    Lin SH; Ji BC; Shih YM; Chen CH; Chan PC; Chang YJ; Lin YC; Lin CH
    Int J Tuberc Lung Dis; 2013 Dec; 17(12):1638-44. PubMed ID: 24200282
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features, etiology and outcomes of community-acquired pneumonia in patients with chronic obstructive pulmonary disease.
    Gómez-Junyent J; Garcia-Vidal C; Viasus D; Millat-Martínez P; Simonetti A; Santos MS; Ardanuy C; Dorca J; Carratalà J
    PLoS One; 2014; 9(8):e105854. PubMed ID: 25166349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epidemiology of clinically diagnosed community-acquired pneumonia in the primary care setting: results from the 1999-2000 respiratory surveillance program.
    Gotfried MH
    Am J Med; 2001 Dec; 111 Suppl 9A():25S-29S; discussion 36S-38S. PubMed ID: 11755440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic inflammatory pattern of patients with community-acquired pneumonia with and without COPD.
    Crisafulli E; Menéndez R; Huerta A; Martinez R; Montull B; Clini E; Torres A
    Chest; 2013 Apr; 143(4):1009-1017. PubMed ID: 23187314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A disease model descriptive of progression between chronic obstructive pulmonary disease exacerbations and community-acquired pneumonia: roles for underlying lung disease and the pharmacokinetics/pharmacodynamics of the antibiotic.
    File TM; Monte SV; Schentag JJ; Paladino JA; Klugman KP; Lavin B; Yu VL; Singer ME; Adelman MH
    Int J Antimicrob Agents; 2009 Jan; 33(1):58-64. PubMed ID: 18835762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of community-acquired pneumonia in chronic obstructive pulmonary disease stratified by smoking status: a population-based cohort study in the United Kingdom.
    Braeken DC; Rohde GG; Franssen FM; Driessen JH; van Staa TP; Souverein PC; Wouters EF; de Vries F
    Int J Chron Obstruct Pulmon Dis; 2017; 12():2425-2432. PubMed ID: 28860737
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical risk factors for admission with Pseudomonas and multidrug-resistant Pseudomonas community-acquired pneumonia.
    Idigo AJ; Wells JM; Brown ML; Wiener HW; Griffin RL; Cutter G; Shrestha S; Lee RA
    Antimicrob Resist Infect Control; 2022 Jul; 11(1):95. PubMed ID: 35836272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Community-acquired pneumonia in chronic obstructive pulmonary disease.
    Cavallazzi R; Ramirez J
    Curr Opin Infect Dis; 2020 Apr; 33(2):173-181. PubMed ID: 32022741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community-acquired pneumonia in patients with and without chronic obstructive pulmonary disease.
    Molinos L; Clemente MG; Miranda B; Alvarez C; del Busto B; Cocina BR; Alvarez F; Gorostidi J; Orejas C;
    J Infect; 2009 Jun; 58(6):417-24. PubMed ID: 19329187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial aetiology and mortality in COPD patients with CAP: results from the German Competence Network, CAPNETZ.
    Braeken DC; Franssen FM; von Baum H; Schütte H; Pletz MW; Rupp J; Stassen F; Mooij MJ; Rohde GG
    Int J Tuberc Lung Dis; 2017 Feb; 21(2):236-243. PubMed ID: 28234091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic obstructive pulmonary disease and mortality from pneumonia: meta-analysis.
    Loke YK; Kwok CS; Wong JM; Sankaran P; Myint PK
    Int J Clin Pract; 2013 May; 67(5):477-87. PubMed ID: 23574107
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is chronic obstructive pulmonary disease a risk factor for death in patients with community acquired pneumonia?
    Bonnesen B; Baunbæk Egelund G; Vestergaard Jensen A; Andersen S; Trier Petersen P; Rohde G; Ravn P
    Infect Dis (Lond); 2019 May; 51(5):340-347. PubMed ID: 30938220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.